Paul Bolaji Invites You to ”Thrombolytic Therapy in Acute Stroke in African Patients” Seminar
Paul Bolaji, Education Lead (Stroke Services) at Dorset County Hospital NHS Foundation Trust, shared on LinkedIn:
”Urgent: Thrombolysis Seminar Next week
Dear Esteemed Audience and Champions of Stroke Care,
Across the continent of Africa, where resilience and innovation shape our healthcare journey, we invite you to ASO–WSO Webinar Series 3, dedicated to advancing lifesaving stroke treatment in Africa.
Theme:
Thrombolytic Therapy in Acute Stroke in African Patients: Early and Extended Window
Why This Matters
It has been over 30 years since the first trials proved that thrombolysis saves lives and reduces disability in acute ischemic stroke.
Yet across Africa, its use remains extremely low.
With stroke striking Africans at younger ages and with more severe outcomes, expanding access to thrombolysis is urgent, achievable, and essential.
This webinar brings leading experts who will discuss evidence, African experience, and practical steps to increase thrombolysis across the continent.
Speakers:
• Prof Ahmed Nasreldein, Assiut University, Egypt
• Dr Paul Bolaji, Dorset County Hospital, UK
Moderators:
• Dr. Sarah Matuja, Tanzania and University of Leicester
• Dr Zakaria Mamadou, General Reference Hospital, Niger
Date and Time:
19 November 2025 | 1:00 PM GMT
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis
-
Jan 12, 2026, 01:45Khurram Nasir on Where The Cholesterol Guidelines Are Headed